Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection.
Burkholderia pseudomallei, a bacterium that causes the disease melioidosis, is intrinsically resistant to many antibiotics. First-line antibiotic therapy for treating melioidosis is usually the synthetic β-lactam, ceftazidime (CAZ), as almost all B. pseudomallei strains are susceptible to this drug....
Huvudupphovsmän: | Sarovich, D, Price, E, Limmathurotsakul, D, Cook, J, Von Schulze, A, Wolken, SR, Keim, P, Peacock, S, Pearson, T |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
2012
|
Liknande verk
Liknande verk
-
Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in Burkholderia pseudomallei.
av: Chantratita, N, et al.
Publicerad: (2011) -
Microevolution of Burkholderia pseudomallei during an acute infection.
av: Limmathurotsakul, D, et al.
Publicerad: (2014) -
Within-host evolution of Burkholderia pseudomallei in four cases of acute melioidosis
av: Price, E, et al.
Publicerad: (2010) -
Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.
av: Dance, D, et al.
Publicerad: (1991) -
Burkholderia pseudomallei infections.
av: Dance, D
Publicerad: (2000)